OncoLink would like to acknowledge the continued support of our corporate sponsors.

OncoLink would like to acknowledge the continued support of our sponsors: Amgen, the world's largest independent biotechnology company; Sanofi-aventis Group, the world's third largest pharmaceutical company. We also appreciate our sponsor AstraZeneca. It is through their generous contributions that we are able to remain among the highest quality cancer information resources on the Web. Lilly Oncology, committed to providing comprehensive health care solutions to oncologists and cancer patients around the world through the discovery and development of novel cancer agents.

We take pride in partnering with our sponsors to provide the highest level cancer-related information for the millions of OncoLink readers. In compliance with our policy and the FDA Guidance on Industry Supported Scientific and Educational Activities, OncoLink develops the educational content on our site independently and without control or influence by our sponsors over the content. Although we mention specific oncology related products for educational purposes, OncoLink remains free of commercial bias for or against our sponsors products thus ensuring the independence and balance of our content.

Our goals are to continue in this endeavor, and to provide enhancements to our present format. We feel that these improvements will facilitate the provision of up-to-date, quality content to the readers. We hope to continue to be one of the premier medical resources on the Web, and vow to continue in pursuit of the high quality our readers deserve.